Clinical Trial Update: Effect of Allopurinol on Markers of Mineral and Bone Metabolism [NA]

View source ↗

Summary

A completed clinical trial examined the effect of allopurinol on markers of mineral and bone metabolism in chronic kidney disease with renal osteodystrophy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Renal Osteodystrophy

Drugs mentioned

• Allopurinol (Allopurinol)

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Chronic Kidney Diseases, Osteodystrophy | NA | Status: COMPLETED